Embecta Shares Up Following Better-Than-Expected 3Q Earnings | The Markets Café
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
Wednesday, March 22, 2023
No Result
View All Result
Subscribe
  • Login
The Markets Café
en English
zh-CN 简体中文en Englishfr Françaisde Deutschhi हिन्दीit Italianoja 日本語pt Portuguêsru Русскийes Españoltr Türkçe
  • News
  • Politics
  • Markets
    • Stocks
    • Futures
    • Commodities
  • Crypto
    • News
    • Markets
    • NFT
    • DeFi
    • Explained
  • Economy
  • Finance
  • Investing
  • Forex
  • Real Estate
  • Tech
  • VideosHOT
  • Community
  • Charts
  • News
  • Politics
  • Markets
    • Stocks
    • Futures
    • Commodities
  • Crypto
    • News
    • Markets
    • NFT
    • DeFi
    • Explained
  • Economy
  • Finance
  • Investing
  • Forex
  • Real Estate
  • Tech
  • VideosHOT
  • Community
  • Charts
No Result
View All Result
The Markets Café
No Result
View All Result
  • News
  • Politics
  • Markets
  • Crypto
  • Economy
  • Finance
  • Forex
  • Investing
  • Tech
  • Videos
  • Community
Home News

Embecta Shares Up Following Better-Than-Expected 3Q Earnings

by Press Room
August 16, 2022
in News
96 7
A A
0
21
SHARES
687
VIEWS
FacebookTwitter

By Connor Hart

Embecta Corp. shares are up after the company on Monday beat Wall Street expectations in its third quarter.

Shares were recently trading at $32.67, up almost 14%

The Parsippany, N.J.-based manufacturer of medical devices used in the treatment of diabetes said net income fell to $62.4 million, compared with $104.7 million in the previous year.

On a per-share basis, the company posted earnings of $1.07, beating FactSet analysts’ estimates of 87 cents a share.

Revenue fell to $291.1 million from $295 million in the year-ago quarter. Analysts polled by FactSet were expecting revenue of $276.9 million.

On a constant currency basis, revenue was up 2% year-over-year, the company said.

The company, which completed its spinoff from Becton, Dickinson & Co. in April of this year, has seen its share price rise almost 30% in the last three months.

Write to Connor Hart at connor.hart@wsj.com

Read the full article here

Related Articles

News

Where Biden Stands Vs. Trump, Obama On 6 Major Issues: Gallup

March 22, 2023
News

How bank chaos triggered wild swings in rate expectations ahead of Fed meeting

March 22, 2023
News

BlueLinx Preliminary Q1 Earnings: Looking Beyond The Near-Term (NYSE:BXC)

March 22, 2023
News

European Spring? Germany Braces For Major Strikes While France Burns

March 22, 2023
News

Arthur J. Gallagher Stock: Expecting A Strong FY23 (NYSE:AJG)

March 22, 2023
News

NATO Shouldn't Trust Hungary And Turkey, Claims German Newspaper Die Welt

March 22, 2023

About Us

The Markets Café

The Markets Cafe is your one stope Finance, Politics and bussines news website, follow us to get the latest news and updates from around the world.

Sections

  • Commodities
  • Crypto Markets
  • Crypto News
  • DeFi
  • Economy
  • Explained
  • Finance
  • Forex
  • Futures
  • Investing
  • Markets
  • News
  • NFT
  • Politics
  • Real Estate
  • Stocks
  • Tech
  • Videos

Site Links

  • Contact
  • Advertise
  • DMCA
  • Submit Article
  • Forum
  • Site info
  • Newsletter

Newsletter

THE MOST IMPORTANT FINANCE NEWS AND EVENTS OF THE DAY

Subscribe to our mailing list to receives daily updates direct to your inbox!

  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact

© 2022 The Markets Café - All rights reserved.

No Result
View All Result
  • News
  • Politics
  • Markets
    • Stocks
    • Futures
    • Commodities
  • Crypto
    • News
    • Markets
    • NFT
    • DeFi
    • Explained
  • Economy
  • Finance
  • Investing
  • Forex
  • Real Estate
  • Tech
  • Videos
  • Community
  • Charts

© 2022 The Markets Café - All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.